Literature DB >> 7648676

Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study.

J Zhang1, D J Duncker, X Ya, Y Zhang, T Pavek, H Wei, H Merkle, K Uğurbil, A H From, R J Bache.   

Abstract

BACKGROUND: This study tested the hypothesis that 31P nuclear magnetic resonance (NMR)-detectable 2-deoxyglucose (2DG) uptake is increased in chronically pressure-overloaded hypertrophied left ventricular myocardium. METHODS AND
RESULTS: 31P NMR spectroscopy was used to determine the transmural distribution of high-energy phosphate levels and 2-deoxyglucose-6-phosphate (2DGP) accumulation during intracoronary infusion of 2DG (15 mumol.kg body wt-1.min-1) in eight normal dogs and in eight dogs with severe left ventricular hypertrophy (LVH) produced by ascending aortic banding. The ratio of LV weight to body weight was 8.25 +/- 0.65 g/kg in the LVH group compared with 4.35 +/- 0.11 g/kg in the normal group (P < .01). Myocardial ATP content was decreased by approximately 40% and phosphocreatine (PCr) by approximately 60% in LVH hearts. ATP values were transmurally uniform in LVH and normal hearts, whereas PCr was lower in the subendocardium (Endo) than the subepicardium (Epi) of both groups. The PCr/ATP ratio was lower in LVH hearts (1.72 +/- 0.05, 1.64 +/- 0.07, and 1.53 +/- 0.10 in Epi, midwall, and Endo, respectively) compared with normal hearts (2.36 +/- 0.05, 2.09 +/- 0.06, and 1.96 +/- 0.06; each P < .01 normal versus LVH). Arterial blood levels of glucose, insulin, and free fatty acids were comparable between groups, whereas arterial lactate and norepinephrine levels were significantly higher in the LVH group. 2DG infusion did not affect systemic hemodynamics or myocardial high-energy phosphate or inorganic phosphate levels in either group. At the end of 60 minutes of 2DG infusion, there was no detectable accumulation of 2DGP in the normal hearts. However, seven of the eight LVH hearts showed time-dependent accumulation of 2DGP, which was linearly related to the severity of hypertrophy (r = .90 for subendocardial 2DGP versus LV weight/body weight). A transmural gradient of 2DGP was present, with greatest accumulation in the subendocardium (3.3 +/- 1.6, 5.8 +/- 2.3, and 7.9 +/- 2.2 mumol/g in Epi, midwall, and Endo of the LVH hearts, respectively; P < .05 Epi versus Endo).
CONCLUSIONS: The pressure-overloaded hypertrophied left ventricle demonstrated increased accumulation of 2DGP detected with 31P NMR spectroscopy. Accumulation of 2DGP was positively correlated with the degree of hypertrophy and was most marked in the subendocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648676     DOI: 10.1161/01.cir.92.5.1274

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

Review 1.  Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques?

Authors:  Gautam V Ramani; Gagandeep Gurm; Vasken Dilsizian; Myung H Park
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 2.  The use of magnetic resonance methods in translational cardiovascular research.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  J Cardiovasc Transl Res       Date:  2009-01-13       Impact factor: 4.132

3.  Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction.

Authors:  Mohammad Nurulqadr Jameel; Qinglu Li; Abdul Mansoor; Xiong Qiang; Aaron Sarver; Xiaohong Wang; Cory Swingen; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

Review 4.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

Review 5.  Advantages and limitations of experimental techniques used to measure cardiac energy metabolism.

Authors:  G D Lopaschuk
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

Review 6.  Cardiac mitochondrial matrix and respiratory complex protein phosphorylation.

Authors:  Raul Covian; Robert S Balaban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

Review 7.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 8.  Role of YAP/TAZ in Energy Metabolism in the Heart.

Authors:  Toshihide Kashihara; Junichi Sadoshima
Journal:  J Cardiovasc Pharmacol       Date:  2019-12       Impact factor: 3.105

9.  GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.

Authors:  Renata O Pereira; Adam R Wende; Curtis Olsen; Jamie Soto; Tenley Rawlings; Yi Zhu; Christian Riehle; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2014-02-25       Impact factor: 5.000

10.  Myocardial energetics in left ventricular hypertrophy.

Authors:  Mohammad N Jameel; Jianyi Zhang
Journal:  Curr Cardiol Rev       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.